
AffinityAI is a Danish biotech company specializing in AI-driven design of custom protein binders called Designerbodies™. Their proprietary ARCANE™ and RAVEN™ platforms enable rapid, animal-free development of high-affinity, thermostable, and highly expressible protein binders with known epitope specificity. These Designerbodies™ serve pharmaceutical, biotech, academic, and clinical lab customers by accelerating drug development, diagnostics, and research with faster, cost-effective, and sustainable alternatives to traditional antibodies. The company is led by a team of scientists with deep expertise in protein design and expression, supported by experienced advisors from life sciences and pharma sectors. AffinityAI's business model is based on providing custom protein binder design and expression services, delivering products 5x faster than conventional methods, with detailed structural information and scalable production capabilities.

AffinityAI is a Danish biotech company specializing in AI-driven design of custom protein binders called Designerbodies™. Their proprietary ARCANE™ and RAVEN™ platforms enable rapid, animal-free development of high-affinity, thermostable, and highly expressible protein binders with known epitope specificity. These Designerbodies™ serve pharmaceutical, biotech, academic, and clinical lab customers by accelerating drug development, diagnostics, and research with faster, cost-effective, and sustainable alternatives to traditional antibodies. The company is led by a team of scientists with deep expertise in protein design and expression, supported by experienced advisors from life sciences and pharma sectors. AffinityAI's business model is based on providing custom protein binder design and expression services, delivering products 5x faster than conventional methods, with detailed structural information and scalable production capabilities.